Pioglitazone deuterated (DeuteRx)

N/A

Report date: 2025/08/15 14:29:37
NME

Base Information

Drug NamePioglitazone deuterated (DeuteRx)
Drug Alias NameDeuterated pioglitazoneDeuterium stabilised enantiomer pioglitazonedeuterated R-pioglitazonedeuterium-stabilized R-pioglitazoneR-Pioglitazone +[9] 
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonists
TargetsPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDeuterx
China Registration ClassN/A

Develop Information

Active CompaniesPoxel Sa
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A